Tiotropium might improve survival in subjects with COPD at high risk of mortality.
about
An Official American Thoracic Society/European Respiratory Society Statement: Research questions in chronic obstructive pulmonary disease.Once-daily glycopyrronium bromide (Seebri Breezhaler(®)) for the treatment of chronic obstructive pulmonary disease (COPD).UPLIFT study - understanding potential long-term impacts on function with tiotropium - and sub-analyses. Bibliographic resume of the obtained results.Efficacy of Tiotropium Bromide and Rehabilitation Treatment on Pulmonary Function of Patients With Sulfur Mustard Lung Injury.Does the Term "Deflators" Reflect More Accurately the Beneficial Effects of Long-acting Bronchodilators in COPD?
P2860
Tiotropium might improve survival in subjects with COPD at high risk of mortality.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Tiotropium might improve survival in subjects with COPD at high risk of mortality.
@ast
Tiotropium might improve survival in subjects with COPD at high risk of mortality.
@en
type
label
Tiotropium might improve survival in subjects with COPD at high risk of mortality.
@ast
Tiotropium might improve survival in subjects with COPD at high risk of mortality.
@en
prefLabel
Tiotropium might improve survival in subjects with COPD at high risk of mortality.
@ast
Tiotropium might improve survival in subjects with COPD at high risk of mortality.
@en
P2093
P2860
P356
P1433
P1476
Tiotropium might improve survival in subjects with COPD at high risk of mortality
@en
P2093
Armin Furtwaengler
Dacheng Liu
Daniel Dusser
Jean-Louis Paillasseur
Marc Decramer
Norbert Metzdorf
UPLIFT® Study Investigators
Yufeng Liu
P2860
P2888
P356
10.1186/1465-9921-15-64
P577
2014-06-10T00:00:00Z
P5875
P6179
1018468947